Self-Host
Tools / Inside Trading Tracker
Inside Trading Tracker
Track insider trading activity at publicly traded companies to understand how executives are trading their shares.
2seventy bio, Inc. (TSVT) Insider Trading Activity
Healthcare • Biotechnology • 274 employees
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. The company's products pipeline includes Abecma, a chimeric antigen receptor T-cell product candidates for the treatment of multiple myeloma. It has a collaboration arrangement with Bristol Myers Squibb Company. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts.
Total Value
-$15,973.65
Total Shares
987,010
Average Trade Value
-$998.35
Most Active Insider
Snow Jessica
Total Activity: $46,973
Largest Single Transaction
$33,760
by Snow Jessica on Aug 14, 2024
30-Day Activity
1 Transaction
Volume: 3,900 shares
Value: $13,182
|
Name
|
Position
|
Date
|
Shares
|
Value
|
Holdings
|
Type
|
|---|---|---|---|---|---|---|
| Nov 18, 2024 | 3,900 | $13,182 | 23,752 (-16.4%) | Sale | ||
|
See Remarks
|
Oct 3, 2024 | 679 | $3,157 | 155,766 (-0.4%) | Sale | |
|
Chief Financial Officer
|
Oct 3, 2024 | 1,230 | $5,718 | 340,089 (-0.4%) | Sale | |
|
See Remarks
|
Aug 14, 2024 | 7,816 | $33,760 | 156,330 (-5.0%) | Sale | |
|
Chief Financial Officer
|
Aug 5, 2024 | 13 | $52 | 341,319 (-0.0%) | Sale | |
|
See Remarks
|
Jul 2, 2024 | 14 | $56 | 164,146 (-0.0%) | Sale | |
|
Chief Financial Officer
|
Jul 2, 2024 | 12 | $48 | 341,332 (-0.0%) | Sale | |
|
President and CEO
|
Jul 1, 2024 | 586,022 | $10,000 | 894,607 (+65.5%) | Grant | |
|
Chief Financial Officer
|
Jul 1, 2024 | 245,864 | $0 | 341,344 (+72.0%) | Grant | |
|
See Remarks
|
Jul 1, 2024 | 108,538 | $10,000 | 164,160 (+66.1%) | Grant | |
| Jun 10, 2024 | 12,050 | $10,000 | 27,652 (+43.6%) | Grant | ||
| Jun 10, 2024 | 12,050 | $10,000 | 32,850 (+36.7%) | Grant | ||
| Jun 10, 2024 | 12,050 | $0 | 27,652 (+43.6%) | Grant | ||
| Jun 10, 2024 | 6,025 | $0 | 22,625 (+26.6%) | Grant | ||
| Jun 10, 2024 | 12,050 | $0 | 31,560 (+38.2%) | Grant | ||
|
Director
|
Jun 10, 2024 | 6,025 | $0 | 22,625 (+26.6%) | Grant |